We are live on ! Find out more
TCM

Traynor Capital Management Portfolio holdings

AUM $2.18B
1-Year Est. Return 62.36%
This Fund
S&P 500
This Quarter Est. Return
+7.74%
1 Year Est. Return
+62.36%
3 Year Est. Return
+225.14%
5 Year Est. Return
+309.6%
10 Year Est. Return
+1,325.66%
AUM
$141M
AUM Growth
+$13.6M
Cap. Flow
+$8.05M
Cap. Flow %
5.69%
Top 10 Hldgs %
44.78%
Holding
141
New
13
Increased
69
Reduced
42
Closed
14

Sector Composition

Rank Sector Weight
1 Communication Services 10.18%
2 Technology 10.14%
3 Healthcare 8.29%
4 Consumer Discretionary 6.27%
5 Energy 4.51%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
STZ icon
26
Constellation Brands
STZ
$22.4B
$1.41M 1%
8,414
+1,023
+14% +$169K
MMM icon
27
3M
MMM
$91.8B
$1.35M 0.95%
9,488
+1,140
+14% +$170K
MO icon
28
Altria Group
MO
$113B
$1.26M 0.89%
20,442
+6,883
+51% +$457K
CELG
29
DELISTED
Celgene Corp
CELG
$1.24M 0.88%
12,389
+131
+1% +$14.2K
BIV icon
30
Vanguard Intermediate-Term Bond ETF
BIV
$28.9B
$1.16M 0.82%
13,332
+6,471
+94% +$568K
PML
31
PIMCO Municipal Income Fund II
PML
$486M
$1.15M 0.82%
89,259
+7,424
+9% +$102K
UAA icon
32
Under Armour
UAA
$2.88B
$1.1M 0.78%
28,349
+3,776
+15% +$153K
PMF
33
DELISTED
PIMCO Municipal Income Fund
PMF
$1.04M 0.74%
63,600
-8,346
-12% -$140K
JPM icon
34
JPMorgan Chase
JPM
$960B
$1.01M 0.71%
14,784
-872
-6% -$56.9K
BRK.B icon
35
Berkshire Hathaway Class B
BRK.B
$1.11T
$964K 0.68%
6,661
-131
-2% -$19.2K
PFE icon
36
Pfizer
PFE
$145B
$945K 0.67%
30,560
+1,304
+4% +$43.6K
NMZ icon
37
Nuveen Municipal High Income Opportunity Fund
NMZ
$2.19B
$828K 0.59%
61,041
-4,154
-6% -$61.8K
PHK
38
PIMCO High Income Fund
PHK
$873M
$812K 0.57%
84,349
+26,197
+45% +$260K
REGN icon
39
Regeneron Pharmaceuticals
REGN
$78B
$804K 0.57%
2,185
-105
-5% -$42.1K
BAC icon
40
Bank of America
BAC
$443B
$795K 0.56%
48,292
-1,199
-2% -$17.9K
CVX icon
41
Chevron
CVX
$380B
$783K 0.55%
7,664
+31
+0.4% +$3.17K
IBB icon
42
iShares Biotechnology ETF
IBB
$9.28B
$777K 0.55%
8,724
+1,218
+16% +$116K
JNJ icon
43
Johnson & Johnson
JNJ
$608B
$762K 0.54%
6,655
+778
+13% +$94.4K
ATW
44
DELISTED
Atwood Oceanics
ATW
$720K 0.51%
75,698
-8,327
-10% -$79K
UPS icon
45
United Parcel Service
UPS
$91.5B
$701K 0.5%
6,490
+1,004
+18% +$110K
NBIX icon
46
Neurocrine Biosciences
NBIX
$17.1B
$686K 0.48%
15,496
-750
-5% -$37.4K
EFA icon
47
iShares MSCI EAFE ETF
EFA
$79.1B
$679K 0.48%
11,662
-1,187
-9% -$68.8K
V icon
48
Visa
V
$687B
$678K 0.48%
8,196
+7
+0.1% +$560
SBUX icon
49
Starbucks
SBUX
$119B
$653K 0.46%
12,293
+643
+6% +$36K
PM icon
50
Philip Morris
PM
$288B
$624K 0.44%
6,506
+166
+3% +$16.6K

Similar funds

Traynor Capital Management's Q3 2016 Portfolio in Review

As of Q3 2016, Traynor Capital Management held 141 positions worth $141M, up 11% from $128M the previous quarter. Its ten largest holdings account for 45% of the portfolio.

Traynor Capital Management deployed $8.05M of net new capital in Q3 2016, opening 13 new positions and adding to 69 existing holdings. Its largest new stake was Direxion Daily Small Cap Bull 3x ETF: 39,814 shares worth $1.48M.

By sector, the portfolio is most concentrated in Communication Services at 10% of assets, up from 9.1% a quarter earlier, followed by Technology and Healthcare.

On the sell side, the largest reduction was Novo Nordisk, an estimated $254K trimmed.

  • Traynor Capital Management's largest Q3 2016 buy was Direxion Daily Small Cap Bull 3x ETF: 39,814 shares worth $1.48M.
  • Traynor Capital Management added most to iShares iBoxx $ Investment Grade Corporate Bond ETF in Q3 2016, an estimated $868K increase.
  • Traynor Capital Management's biggest Q3 2016 reduction was Novo Nordisk, cutting an estimated $254K.
  • Traynor Capital Management fully exited Thermo Fisher Scientific in Q3 2016, selling an estimated $1.28M.
  • Traynor Capital Management's ten largest holdings make up 45% of its $141M portfolio in Q3 2016.
  • Traynor Capital Management opened 13 new positions and closed 14 in Q3 2016.
  • Traynor Capital Management's portfolio value rose 11% quarter-over-quarter to $141M.

Based on Traynor Capital Management's 13F filing for Q3 2016, filed 10 Nov 2016.